Moderna eyes producing vaccine in Asia after Japan rejected AstraZeneca – Nikkei

Dhwani Mehta FXStreet

Amid mixed vaccine developments, Moderna is considering manufacturing its covid vaccine in Japan while the country’s said it will not approve the AstraZeneca vaccine for the time being.

The government will continue monitoring blood clot cases overseas, as a side-effect of AstraZeneca’s covid vaccine.

Meanwhile, Moderna’s Chief Executive Stephane Bancel said in an interview with the Nikkei Asian Review, "We're having discussions in several countries in Asia, including Japan."

The Japanese government has made a contract with Moderna and is set to receive 50 million doses by September.

Bancel said the company is in discussions with Japan regarding additional supplies for next year. "If the government wants 50 million doses [for 2022] we can do that," he added.

Asian Stock Market: Sluggish amid mixed clues, cautious sentiment

Author

Dhwani Mehta

FXStreet

Residing in Mumbai (India), Dhwani is a Senior Analyst and Manager of the Asian session at FXStreet. She has over 10 years of experience in analyzing and covering the global financial markets, with specialization in Forex and commodities markets.

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

Editor's Picks

EUR/USD declines toward 1.1700 on solid USD recovery

EUR/USD turns south and declines toward 1.1700 on Wednesday. A solid comeback staged by the US Dollar weighs heavily on the pair, as traders look to USD short covering ahead of US CPI on Thursday. However, the downside could be capped by hawkish ECB expectations.

GBP/USD slides toward 1.3300 after softer-than-expected UK inflation data

GBP/USD has come under intense selling pressure, eyeing 1.3300 in the European session on Wednesday. The UK annual headline and core CPI rose by 3.2% each, missing estimates of 3.5% and 3.4%, respectively, reaffirming dovish BoE expectations and smashing the Pound Sterling across the board.

Gold clings to modest gains above $4,300

Following Tuesday's volatile action, Gold regains its traction on Wednesday and trades in positive territory above $4,300. While the buildup in the USD recovery momentum caps XAU/USD's upside, the cautious market stance helps ithe pair hold its ground.